Literature DB >> 33506870

A systematic review of general practice-based pharmacists' services to optimize medicines management in older people with multimorbidity and polypharmacy.

Ameerah S Hasan Ibrahim1, Heather E Barry1, Carmel M Hughes1.   

Abstract

BACKGROUND: Few studies have evaluated roles of general practice-based pharmacists (PBPs), particularly in optimizing medicines management for older people with both multimorbidity and polypharmacy.
OBJECTIVE: To explore the types and effectiveness of services provided by PBPs, either alone or in collaboration with other primary health care professionals, that sought to optimize medicines management for older people with multimorbidity and polypharmacy.
METHODS: Eight electronic databases and three trial registries were searched for studies published in English until April 2020. Inclusion criteria were randomized controlled trials, non-randomized controlled trials and controlled before-and-after studies of services delivered by PBPs in primary care/general practice, for patients aged ≥65 years with both multimorbidity and polypharmacy that focused on a number of outcomes. The Cochrane risk of bias tool for randomized trials (RoB 1) and the Risk of Bias in Non-randomized Studies-of Interventions (ROBINS-I) assessment tool were used for quality assessment. A narrative synthesis was conducted due to study heterogeneity.
RESULTS: Seven studies met inclusion criteria. All included studies employed PBP-led medication review accompanied by recommendations agreed and implemented by general practitioners. Other patient-level and practice-level interventions were described in one study. The limited available evidence suggested that PBPs, in collaboration with other practice team members, had mixed effects on outcomes focused on optimizing medicines management for older people. Most included studies were of poor quality and data to estimate the risk of bias were often missing.
CONCLUSION: Future high-quality studies are needed to test the effects of PBP interventions on a well-defined range of medicines management-related outcomes.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Multimorbidity; older people; polypharmacy; practice-based pharmacists; primary health care; systematic review

Year:  2021        PMID: 33506870     DOI: 10.1093/fampra/cmaa146

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  5 in total

1.  A pharmacist-led intervention to improve the management of opioids in a general practice: a qualitative evaluation of participant interviews.

Authors:  Margaret Jordan; Meredith Young-Whitford; Judy Mullan; Adele Stewart; Timothy F Chen
Journal:  Int J Clin Pharm       Date:  2021-11-09

2.  General practitioners' experiences with, views of, and attitudes towards, general practice-based pharmacists: a cross-sectional survey.

Authors:  Ameerah S Hasan Ibrahim; Heather E Barry; Carmel M Hughes
Journal:  BMC Prim Care       Date:  2022-01-14

3.  Information exchange networks for chronic diseases in primary care practices in Germany: a cross-sectional study.

Authors:  Christine Arnold; Patrick Hennrich; Michel Wensing
Journal:  BMC Prim Care       Date:  2022-03-28

4.  'He or she maybe doesn't know there is such a thing as a review': A qualitative investigation exploring barriers and facilitators to accessing medication reviews from the perspective of people from ethnic minority communities.

Authors:  Anna Robinson; Laura Sile; Thorrun Govind; Harpreet Kaur Guraya; Nicola O'Brien; Vicki Harris; Guy Pilkington; Adam Todd; Andy Husband
Journal:  Health Expect       Date:  2022-04-05       Impact factor: 3.318

Review 5.  Clinical pharmacists in Dutch general practice: an integrated care model to provide optimal pharmaceutical care.

Authors:  Ankie Hazen; Vivianne Sloeserwij; Bart Pouls; Anne Leendertse; Han de Gier; Marcel Bouvy; Niek de Wit; Dorien Zwart
Journal:  Int J Clin Pharm       Date:  2021-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.